This federal contract award, with an ID of SPE2DB22D1106|SPE2DB25FDQB2, is for the delivery of Pfizer COVID-19 vaccines for the 2024-2025 time period, with a potential value of $7,125.69. The contract is a Delivery Order placed by the Defense Logistics Agency (DLA), a defense agency, with Amerisourcebergen Drug Corp, a major pharmaceutical distributor, as the prime contractor. The contract is for the delivery of 0.9 mL EUA (Emergency Use Authorization) COVID-19 vaccines and does not have a set-aside designation, indicating open competition. The contract has an ultimate completion date of January 3, 2025, and was awarded on December 11, 2024. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov) and has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 3/12/25, 9:58 AM